EMV.AX

Healthcare Medical Devices

EMVision Medical Devices Ltd

A$1.62

+0.06 +3.85% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 11:38 AM ET	1.62

Key Stats

Market Cap

150.59M

Avg Volume

32,630

EPS

-A$0.09

52W High

A$1.96

52W Low

A$1.47

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-12.46

P/B Ratio

9.53

P/S Ratio

18.02

EV/EBITDA

-15.51

EV/Revenue

15.71

Margins

Gross Margin 100.0%

Operating Margin (100.8%)

Net Margin (99.5%)

EBITDA Margin (101.3%)

Growth & Returns

Revenue Growth (YoY)

187.5%

Return on Equity

(66.4%)

Return on Assets

(27.8%)

Liquidity & Leverage

Current Ratio

5.53

Quick Ratio

5.47

Debt / Equity

0.22

Total Cash

17.10M

Total Debt

3.41M

About

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.